Compare ERIC & IDXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ERIC | IDXX |
|---|---|---|
| Founded | 1876 | 1983 |
| Country | Sweden | United States |
| Employees | 88826 | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.9B | 43.6B |
| IPO Year | N/A | 1996 |
| Metric | ERIC | IDXX |
|---|---|---|
| Price | $12.64 | $565.62 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 9 |
| Target Price | $11.00 | ★ $721.67 |
| AVG Volume (30 Days) | ★ 9.8M | 578.0K |
| Earning Date | 04-17-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.82% | N/A |
| EPS Growth | N/A | ★ 22.59 |
| EPS | N/A | ★ 3.47 |
| Revenue | N/A | ★ $4,303,702,000.00 |
| Revenue This Year | N/A | $10.88 |
| Revenue Next Year | $1.83 | $8.59 |
| P/E Ratio | ★ $12.13 | $162.01 |
| Revenue Growth | N/A | ★ 10.42 |
| 52 Week Low | $7.16 | $507.55 |
| 52 Week High | $13.77 | $769.98 |
| Indicator | ERIC | IDXX |
|---|---|---|
| Relative Strength Index (RSI) | 49.54 | 53.46 |
| Support Level | $9.37 | $550.28 |
| Resistance Level | N/A | $589.82 |
| Average True Range (ATR) | 0.33 | 14.87 |
| MACD | -0.09 | 2.31 |
| Stochastic Oscillator | 12.70 | 72.40 |
Ericsson is a networking equipment and software provider, primarily selling mobile networking equipment and services to wireless service providers. Ericsson operates in three segments: networks, cloud software and services, and enterprise. While large wireless carriers are its largest customers, Ericsson has expanded its offerings for large enterprises. These products and services include private 5G networking, contact centers as a service, and application performance interfaces. Ericsson aims to combine its 5G network expertise with cloud-native, as-a-service platforms offering a more comprehensive hardware and software package. Ericsson also monetizes its research and development investments by licensing patents to handset manufacturers.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.